{"id":127502,"date":"2023-07-18T13:53:32","date_gmt":"2023-07-18T13:53:32","guid":{"rendered":"http:\/\/www.brandon.ddtest.info\/multisite-test\/eli-lilly-expects-fda-decision-on-alzheimers-treatment-donanemab-by-the-end-of-the-year-cnbc\/"},"modified":"2023-07-18T13:53:32","modified_gmt":"2023-07-18T13:53:32","slug":"eli-lilly-expects-fda-decision-on-alzheimers-treatment-donanemab-by-the-end-of-the-year-cnbc","status":"publish","type":"post","link":"http:\/\/www.brandon.ddtest.info\/multisite-test\/eli-lilly-expects-fda-decision-on-alzheimers-treatment-donanemab-by-the-end-of-the-year-cnbc\/","title":{"rendered":"Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year – CNBC"},"content":{"rendered":"

\n<\/p>\n

    \n
  1. Eli Lilly expects FDA decision on Alzheimer’s treatment donanemab by the end of the year<\/a>  CNBC<\/font><\/li>\n
  2. US drugmaker: Alzheimer’s development can be slowed down | DW News<\/a>  DW News<\/font><\/li>\n
  3. Drug donanemab seen as turning point in dementia fight<\/a>  BBC<\/font><\/li>\n
  4. Pharmalittle: Data confirm benefits and risks of Lilly Alzheimer’s drug; Medicare aims to pay hospitals to stockpile essential drugs<\/a>  STAT<\/font><\/li>\n
  5. Eli Lilly CEO: Alzheimer’s drug trial shows slowed disease progression by 40-60% in early patients<\/a>  CNBC Television<\/font><\/li>\n
  6. View Full Coverage on Google News<\/a><\/strong><\/li>\n<\/ol>\n\n
    Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

    Eli Lilly expects FDA decision on Alzheimer’s treatment donanemab by the end of the year  CNBC US drugmaker: Alzheimer’s development can be slowed down | DW News  DW News Drug donanemab seen as turning point in dementia fight  BBC Pharmalittle: Data confirm benefits and risks of Lilly Alzheimer’s drug; Medicare aims to pay hospitals to stockpile essential drugs  STAT …<\/p>\n","protected":false},"author":1,"featured_media":127503,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[161],"tags":[],"_links":{"self":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/posts\/127502"}],"collection":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/comments?post=127502"}],"version-history":[{"count":0,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/posts\/127502\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/media\/127503"}],"wp:attachment":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/media?parent=127502"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/categories?post=127502"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/tags?post=127502"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}